Evommune, Inc. Common Stock (EVMN)

Total Costs & Expenses

$34.90M

Quarterly · Period ending: · USD

EVMN logo

EVMN Total Costs & Expenses

Latest reported$34.90M
EVMN Quarterly Total Costs & Expenses ($10.75M → $34.90M)
High-resolution chart · PNG

EVMN total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
34,895,000
23,954,000
29,716,000
23,328,000
22,994,000
18,032,000
18,985,000
16,517,000
28,289,000
10,754,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.